Quarterly report pursuant to Section 13 or 15(d)

RELATED PARTY TRANSACTIONS (Details Narrative)

v3.19.3
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Jul. 28, 2016
Unpaid balance $ 0   $ 0      
Proceeds from royalty     3,000,000      
Related party payables 241,629   241,629   $ 32,318  
Common stock shares issued during the period       12,500    
Common stock shares issued during the period       70,000    
BioCorRx Pharmaceuticals, Inc [Member]            
Ownership percentage hold by former officers           24.20%
Ownership percentage hold by company           75.80%
FFE [Member]            
Unpaid balance 0   0   0  
Monthly remuneration 14,583   14,583      
Consulting fees 43,750 $ 70,750 131,250 $ 151,548    
Mr. Tom Welch, VP of Operations [Member]            
Unpaid balance 0   0   0  
Monthly remuneration 12,500   12,500      
Consulting fees 37,500 57,500 112,500 128,032    
Soupface LLC [Member]            
Unpaid balance         0  
Monthly remuneration 15,833   15,833      
Consulting fees 47,500 75,000 142,500 162,500    
Compensation for services     15,583      
PARS [Member]            
Unpaid balance 0   0   $ 32,318  
Monthly remuneration 14,583   14,583      
Consulting fees $ 0 $ 0 $ 0 $ 0    
Director [Member]            
Common stock shares issued during the period     20,021